Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the US

References

• McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia – an overview. JAMA Psychiatry. 2020;77(2):201–210.
   PubMed Web of Science ®Google Scholar
• GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
   PubMed Web of Science ®Google Scholar
• McGrath J, Saha S, Chant D, et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–76.
   PubMed Web of Science ®Google Scholar
• Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77(6):764–771.
   PubMed Web of Science ®Google Scholar
• Murphy T, Krasa H, Lavigne G, et al. Societal costs of schizophrenia & related disorders. Alexandria (VA): Schizophrenia & Psychosis Action Alliance (US); 2021.
   Google Scholar
• Emsley R, Chiliza B, Asmal L, et al. The nature of relapse in schizophrenia. BMC Psychiatry. 2013;13:50.
   PubMed Web of Science ®Google Scholar
• Barnett I, Torous J, Staples P, et al. Relapse prediction in schizophrenia through digital phenotyping: a pilot study. Neuropsychopharmacology. 2018;43(8):1660–1666.
   PubMed Web of Science ®Google Scholar
• Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–872.
   PubMed Web of Science ®Google Scholar
• Hjorthøj C, Stürup AE, McGrath JJ, et al. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301.
   PubMed Web of Science ®Google Scholar
• Millier A, Schmidt U, Angermeyer MC, et al. Humanistic burden in schizophrenia: a literature review. J Psychiatr Res. 2014;54:85–93.
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Such P, Nylander AG, et al. The burden of disease in early schizophrenia – a systematic literature review. Curr Med Res Opin. 2021;37(1):109–121.
   PubMed Web of Science ®Google Scholar
• Díaz-Caneja CM, Pina-Camacho L, Rodríguez-Quiroga A, et al. Predictors of outcome in early-onset psychosis: a systematic review. NPJ Schizophr. 2015;1:14005.
   PubMed Web of Science ®Google Scholar
• Germain N, Kymes S, Löf E, et al. A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia. J Med Econ. 2019;22(5):403–413.
   PubMed Web of Science ®Google Scholar
• Zhou J, Millier A, François C, et al. Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results. J Mark Access Health Policy. 2019;7(1):1648973.
   PubMedGoogle Scholar
• Aceituno D, Pennington M, Iruretagoyena B, et al. Health state utility values in schizophrenia: a systematic review and Meta-analysis. Value Health. 2020;23(9):1256–1267.
   PubMed Web of Science ®Google Scholar
• Bouwmans C, de Sonneville C, Mulder CL, et al. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–2142.
   PubMed Web of Science ®Google Scholar
• Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand. Curr Med Res Opin. 2008;24(11):3063–3072.
   PubMed Web of Science ®Google Scholar
• Haro JM, Kamath SA, Ochoa S, et al. The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl. 2003;107(416):16–23.
   Google Scholar
• Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28–37.
   PubMedGoogle Scholar
• Qureshi ZP, Khandker R, Shepherd J, et al. Assessment of real-life outcomes in schizophrenia patients according to compliance. Psychiatry J. 2020;2020:1–10.
   Google Scholar
• Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365.
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.
   PubMed Web of Science ®Google Scholar
• Endicott J, Nee J, Harrison W, et al. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321–326.
   PubMed Web of Science ®Google Scholar
• European Pharmaceutical Market Research Association (EphMRA) code of conduct [Internet]. Basel (CH): EphMRA [cited 2021 May 24]. Available from: https://www.ephmra.org/standards/code-of-conduct/
   Google Scholar
• Summary of the Health Insurance Portability and Accountability Act (HIPAA) privacy rule [Internet]. Washington (DC): US Department of Health and Human Services [cited 2021 May 24]. Available from: http://www.hhs.gov/sites/default/files/privacysummary.pdf
   Google Scholar
• International Chamber of Commerce (ICC)/ESOMAR international code on market, opinion and social research and data analytics [Internet]. ICC/ESOMAR [cited 2021 May 24]. Available from: https://www.esomar.org/uploads/public/knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_English_.pdf
   Google Scholar
• Millier A, Horváth M, Ma F, et al. Healthcare resource use in schizophrenia, EuroSC findings. J Mark Access Health Policy. 2017;5(1):1372027.
   PubMedGoogle Scholar
• Glick HA, Li P, Harvey PD. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia Trial. Schizophr Res. 2015;166(1–3):110–114.
   PubMed Web of Science ®Google Scholar
• Marwaha S, Johnson S. Schizophrenia and employment – a review. Soc Psychiatry Psychiatr Epidemiol. 2004;39(5):337–349.
   PubMed Web of Science ®Google Scholar